Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1336 CNY

100%
Buy Us a Coffee

CVE-2021-23236— Fresenius Kabi Agilia Connect Infusion System uncontrolled resource consumption

Quick assessment

Affected
Fresenius Kabi Agilia Link+
Exploitation
No confirmed in-the-wild exploitation; assess based on exposure
Recommended action
Check the vendor advisory and references for a fixed version. If immediate upgrade is impossible, restrict exposure and increase monitoring.

Fresenius Kabi Agilia Connect Infusion System是德国Fresenius Kabi公司的一个输液系统。 Fresenius Kabi Agilia Connect Infusion System存在资源管理错误漏洞，该漏洞源于应用对于恶意请求缺少有效限制，导致不受控制的资源消耗，请求可以用来中断设备的正常运行。当被利用时，Agilia Link+必须通过按下机架系统上的一个按钮触发硬复位来重新启动。

CVSS 7.5 · High EPSS 1.07% · P62
Get alerts for future matching vulnerabilities Log in to subscribe

I. Basic Information for CVE-2021-23236

Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Fresenius Kabi Agilia Connect Infusion System uncontrolled resource consumption
Source: CVE Program / CVE List V5
Vulnerability Description
Requests may be used to interrupt the normal operation of the device. When exploited, Fresenius Kabi Agilia Link+ version 3.0 must be rebooted via a hard reset triggered by pressing a button on the rack system.
Source: CVE Program / CVE List V5
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Source: CVE Program / CVE List V5
Vulnerability Type
未加控制的资源消耗(资源穷尽)
Source: CVE Program / CVE List V5
Vulnerability Title
Fresenius Kabi Agilia Connect Infusion System 资源管理错误漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Fresenius Kabi Agilia Connect Infusion System是德国Fresenius Kabi公司的一个输液系统。 Fresenius Kabi Agilia Connect Infusion System存在资源管理错误漏洞，该漏洞源于应用对于恶意请求缺少有效限制，导致不受控制的资源消耗，请求可以用来中断设备的正常运行。当被利用时，Agilia Link+必须通过按下机架系统上的一个按钮触发硬复位来重新启动。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

Vendor Product Affected Versions CPE Subscribe
Fresenius Kabi Agilia Link+ unspecified ~ 3.0 -

II. Public POCs for CVE-2021-23236

# POC Description Source Link Shenlong Link
AI-Generated POC Premium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2021-23236

请登录查看更多情报信息。

Vendor Advisories for CVE-2021-23236 (1)

Same Patch Batch · Fresenius Kabi · 2022-01-21 · 12 CVEs total

CVE-2021-23196 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System insufficiently protected credentials
CVE-2021-23233 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System
CVE-2021-41835 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algor
CVE-2021-43355 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System use of client side authentication
CVE-2021-23207 6.5 MEDIUM Fresenius Kabi Agilia Connect Infusion System plaintext storage of a password
CVE-2021-31562 6.5 MEDIUM Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algor
CVE-2021-44464 6.3 MEDIUM Fresenius Kabi Agilia Connect Infusion System hard coded credentials
CVE-2021-33846 5.9 MEDIUM Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algor
CVE-2021-33848 5.4 MEDIUM Fresenius Kabi Agilia Connect Infusion System cross site scripting
CVE-2021-23195 5.3 MEDIUM Fresenius Kabi Agilia Connect Infusion System exposure of information through directory li
CVE-2021-33843 5.3 MEDIUM Fresenius Kabi Agilia Connect Infusion System files or directories accessible to external

IV. Related Vulnerabilities

Same product: Agilia Link+
Same vendor: Fresenius Kabi
Same weakness: CWE-400

V. Comments for CVE-2021-23236

No comments yet

Leave a comment